Sanofi and PCPA have signed a letter of intent for dapitol® in the field of dermatology and respiratory care to support patients in obtaining dabitol through the Canadian Public Medicines Program.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.